Protoporphyrin IX-gold nanoparticle conjugates as an efficient photosensitizer in cervical cancer therapy

Photodiagnosis and Photodynamic Therapy

Volumn 10, Issue 3, 2013, Pages 304-312

  Eshghi, Hossein ^a   Sazgarnia, Ameneh ^b   Rahimizadeh, Mohammad ^a   Attaran, Neda ^a   Bakavoli, Mehdi ^a   Soudmand, Samaneh ^b  

^a FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gold nanoparticles; HeLa cells; Photodynamic therapy; Protoporphyrin IX

Indexed keywords

6 MERCAPTO 1 HEXANOL; GOLD NANOPARTICLE; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE; SILVER NANOPARTICLE; SINGLET OXYGEN; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; CELL DENSITY; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; GIEMSA STAIN; HELA CELL; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IRRADIATION; LIGHT EXPOSURE; PHOTODYNAMIC THERAPY; PHOTON; PHOTOSENSITIZATION; PRIORITY JOURNAL; RADIATION ABSORPTION; SURFACE CHARGE; SURVIVAL RATE; TOXICITY TESTING; ULTRAVIOLET SPECTROSCOPY; UTERINE CERVIX CANCER;

GOLD NANOPARTICLES; HELA CELLS; PHOTODYNAMIC THERAPY; PROTOPORPHYRIN IX;

CELL LINE, TUMOR; DRUG THERAPY, COMBINATION; FEMALE; GOLD; HELA CELLS; HUMANS; METAL NANOPARTICLES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84883460190     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2013.02.003     Document Type: Article

References (53)

1. Prosst R.L., Wolfsen H.C., Gahlen J. Photodynamic therapy for esophageal diseases: a clinical update. Endoscopy 2003, 35:1059-1068.
2. Detty M.R., Gibson S.L., Wagner S. Current clinical and preclinical photosensitizers for use in photodynamic therapy. Journal of Medicinal Chemistry 2004, 47:3897-3915.
3. Dougherty T.J., Gomer C.J., Henderson B.W., et al. Photodynamic therapy. Journal of the National Cancer Institute 1998, 90:889-905.
4. Webber J., Kessel D., Fromm D. Photodynamic therapy using endogenous photosensitization for gastrointestinal tumors. Yale Journal of Biology and Medicine 1997, 70:127-137.
5. Stanzel F. Photodynamische therapie in der pneumologie. Pneumologie 2000, 54:269-277.
6. LaMuraglia G.M., Klyachkin M.L., Adili F., Abbott W.M. Photodynamic therapy of vein grafts: suppression of intimal hyperplasia of the vein graft but not the anastomosis. Journal of Vascular Surgery 1995, 21:882-890.
7. Sazgarnia A., Montazerabadi A.R., Bahreyni-Toosi M.H., Ahmadi Pharm A.H., Aledavood A. In vitro survival of MCF-7 breast cancer cells following combined treatment with ionizing radiation and mitoxantrone-mediated photodynamic therapy. Photodiagnosis and Photodynamic Therapy 2012, 10.1016/j.pdpdt.2012.06.001.
8. Magaraggia M., Marigo L., Pagnan A., Jori G., Visonà A. Porphyrin-photosensitized processes: their applications in the prevention of arterial restenosis. Cardiovascular and Hematological Agents in Medicinal Chemistry 2007, 5:278-288.
9. Bonnett R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chemical Society Reviews 1995, 24:19-33.
10. Moan J. On the diffusion length of singlet oxygen in cells and tissues. Journal of Photochemistry and Photobiology B: Biology 1990, 6:343-347.
11. Wang I., Bendsoe N., Klinteberg C.A.F., et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. British Journal of Dermatology 2001, 4:832-840.
12. Klinteberg C.A., Enejder A.M.K., Wang I., Svanberg S., Svanberg K. Kinetic fluorescence studies of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation in basal cell carcinomas. Journal of Photochemistry and Photobiology B: Biology 1999, 49:120-128.
13. CRC Handbook of Organic Photochemistry and Photobiology 2003, 1461-1471. CRC Press, Boca Raton. G. Jori, W. Horspool, F. Lenci (Eds.).
14. Xiao Z., Tamimi Y., Brown K., Tulip J., Moore R. Interstitial photodynamic therapy in subcutaneously implanted urologic tumors in rats after intravenous administration of 5-amino-levulinic acid. Urologic Oncology 2002, 7:125-132.
15. Ericson M.B., Grapengiesser S., Gudmundson F., et al. A spectroscopic study of the photobleaching of protoporphyrin IX in solution. Lasers in Medical Science 2003, 18:56-62.
16. Allen C.M., Sharman W.M., Van Lier J.E. Current status of phthalocyanines in the photpdynamic therapy of cancer. Journal of Porphyrins and Phthalocyanines 2001, 5:161-169.
17. Konan Y.N., Gruny R., Allemann E. State of the art in the delivery of photosensitizers for photodynamic therapy. Journal of Photochemistry and Photobiology B: Biology 2002, 66:89-106.
18. Dolmans D.E.J.G.J., Fukumura D., Jain R.K. Photodynamic therapy for cancer. Nature Reviews. Cancer 2003, 3:380-387.
19. Boyle R.W., Dolphin D. Structure and biodistribution relationships of photodynamic sensitizers. Photochemistry and Photobiology 1996, 64:469-485.
20. ® photosensitization of MCF-7 human breast cancer cells. Photochemistry and Photobiology 2003, 78:9-14.
21. Roby A., Erdogan S., Torchilin V.P. Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro. European Journal of Pharmaceutics and Biopharmaceutics 2006, 62:235-240.
22. Paciotti G.F., Kingston D.G.I., Tamarkin L. Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors. Drug Development Research 2006, 67:47-54.
23. Wang S.Z., Gao R.M., Zhou F.M., Selke M. Nanomaterials and singlet oxygen photosensitizers: potential applications in photodynamic therapy. Journal of Materials Chemistry 2004, 14:487-493.
24. Obata M., Hirohara S., Tanaka R., et al. In vitro heavy-atom effect of palladium(II) and platinum(II) complexes of pyrrolidine-fused chlorin in photodynamic therapy. Journal of Medicinal Chemistry 2009, 52:2747-2753.
25. McGlynn S.P., Azumi T., Kinoshita M. Molecular Spectroscopy of the Triplet State 1969, Prentice-Hall, Englewood Cliffs, NJ.
26. Justin G. Electrochemical DNA hybridization biosensors. Electroanalysis 2002, 14:1149-1156.
27. Trudel S. Unexpected magnetism in gold nanostructures: making gold even more attractive. Gold Bulletin 2011, 44:3-13.
28. Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983, 65:55-63.
29. Roy I., Ohulchanskyy T.Y., Pudavar H.E., et al. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. Journal of the American Chemical Society 2003, 125:7860-7865.
30. Wu R.W.K., Yow C.M.N., Wong C.K., Lam Y.H. Photodynamic therapy (PDT)-initiation of apoptosis via activation of stress-activated p38 MAPK and JNK signal pathway in H460 cell lines. Photodiagnosis and Photodynamic Therapy 2011, 8:254-263.
31. Chu E.S.M., Yow C.M.N. Modulation of telomerase and signal transduction proteins by Hexyl-ALA-photodynamic therapy (PDT) in human doxorubicin resistant cancer cell models. Photodiagnosis and Photodynamic Therapy 2012, 9:243-255.
32. Fernández J.M., Forbes N.S., Han G., Hong R., Kim B.J., Rotello V.M. Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. Journal of the American Chemical Society 2006, 128:1078-1079.
33. Mansoori G.A., Brandenburg K.S., Shakeri-Zadeth A. A comparative study of two folate-conjugated gold nanoparticles for cancer nanotechnology applications. Cancers 2010, 2:1911-1928.
34. Shakeri-Zadeh A., Eshghi H., Mansoori G.A., Hashemian A.R. Gold nanoparticles conjugated with folic acid using mercaptohexanol as the linker. Journal Nanotechnology Progress International (JONPI) 2009, 1:13-23.
35. Hashemian A.R., Eshghi H., Mansoori G.A., Shakeri-Zadeh A. Folate-conjugated gold nanoparticles (synthesis, characterization and design for cancer cells nanotechnology-based targeting). International Journal of NanoScience and Nanotechnology 2010, 5:25-33.
36. Shakeri-Zadeh A., Mansoori G.A., Hashemian A.R., Eshghi H., Sazgarnia A., Montazerabadi A.R. Cancerous cells targeting and destruction using folate conjugated gold nanoparticles. Dynamic Biochemistry, Process Biotechnology and Molecular Biology 2010, 4:6-12.
37. Eshghi H., Attaran N., Sazgarnia A., Mirzaie N., Shanei A. Synthesis and characterisation of new designed protoporphyrin-stabilised gold nanoparticles for cancer cells nanotechnology-based targeting. International Journal of Nanotechnology 2011, 8:700-711.
38. Shon Y.S., Choi D., Dare J., Dinh T. Synthesis of nanoparticle-cored dendrimers by convergent dendritic functionalization of monolayer-protected nanoparticles. Langmuir 2008, 24:6924-6931.
39. Wieder M.E., Hone D.C., Cook M.J., Handsley M.M., Gavrilovic J., Russell D.A. Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a 'Trojan horse'. Photochemical and Photobiological Sciences 2006, 5:727-734.
40. Christensen S.T., Kemp K., Quie H., Rasmussen L. Cell death, survival and proliferation in tetrahymena thermophila, effects of insulin, sodium nitroprusside, 8-bromo cyclic GMP, NG-methyl-l-arginine and methylene blue. Cell Biology International 1996, 20:653-666.
41. Lu Sh, Xia D., Huang G., Jing H., Wang Y., Gu H. Concentration effect of gold nanoparticles on proliferation of keratinocytes. Colloids and Surfaces B: Biointerfaces 2010, 81:406-411.
42. Agarwal M.L., Clay M.E., Harvey E.J., Evans H.H., Antunez A.R., Oleinick N.L. Photodynamic therapy induces rapid cell death by apotosis in L5178Y mouse lymphoma cells. Cancer Research 1991, 51:5993-5996.
43. Li Q., Cheng J., Peng C., et al. Apoptosis of vascular smooth muscle cells induced by photodynamic therapy with protoporphyrin IX. Biochemical and Biophysical Research Communications 2010, 391:69-72.
44. Noodt B.B., Berg K., Stokke T., Peng Q., Nesland J.M. Apoptosis and necrosis induced with light and 5-aminolevulinic acid-derived protoporphyrin IX. British Journal of Cancer 1996, 74:22-29.
45. Dahle J., Mikalsen S.O., Rivedal E., Steen H.B. Gap junctional intercellular communication is not a major mediator in the bystander effect in photodynamic treatment of MDCK II cells. Radiation Research 2000, 154:331-341.
46. Qian J., Gharibi A., He S. Colloidal mesoporous silica nanoparticles with protoporphyrin IX encapsulated for photodynamic therapy. Journal of Biomedical Optics 2009, 14:014012.
47. Ariffin S.H.Z., Haryani W.H., Omar W., et al. Intrinsic anticarcinogenic effects of Piper sarmentosum ethanolic extract on a human hepatoma cell line. Cancer Cell International 2009, 9:6-14.
48. Oka Y., Naomoto Y., Yasuoka Y., et al. Apoptosis in cultured human colon cancer cells induced by combined treatments with 5-fluorouracil, tumor necrosis factorα and interferonα. Japanese Journal of Clinical Oncology 1997, 27:231-235.
49. Zhao Q.L., Kondo T., Noda A., Fujiwara Y. Mitochondrial and intracellular free-calcium regulation of radiation-induced apoptosis in human leukemic cells. International Journal of Radiation Biology 1999, 75:493-504.
50. Singh N.P. A simple method for accurate estimation of apoptotic cells. Experimental Cell Research 2000, 256:328-337.
51. Masters J.R. HeLa cells 50 years on: the good, the bad and the ugly. Nature Reviews. Cancer 2002, 2:315-319.
52. Hai-yan W., You-zhong Z., Kan J., Hui J., Zhao-jing W. Effects of photodynamic therapy with 5-aminolevulinic acid on apoptosis of human cervical carcinoma Hela and Siha cells in vitro. Journal of Shandong University (Health Sciences) 2010, 48:31-35.
53. Xiang W., Weingandt H., Ließmann F., et al. Photodynamic effects induced by aminolevulinic acid esters on human cervical carcinoma cells in culture. Photochemistry and Photobiology 2001, 74:617-623.